全文获取类型
收费全文 | 1850篇 |
免费 | 100篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 34篇 |
妇产科学 | 35篇 |
基础医学 | 131篇 |
口腔科学 | 75篇 |
临床医学 | 131篇 |
内科学 | 546篇 |
皮肤病学 | 20篇 |
神经病学 | 81篇 |
特种医学 | 67篇 |
外科学 | 408篇 |
综合类 | 43篇 |
一般理论 | 4篇 |
预防医学 | 95篇 |
眼科学 | 56篇 |
药学 | 88篇 |
中国医学 | 2篇 |
肿瘤学 | 106篇 |
出版年
2024年 | 1篇 |
2023年 | 17篇 |
2022年 | 40篇 |
2021年 | 110篇 |
2020年 | 49篇 |
2019年 | 45篇 |
2018年 | 62篇 |
2017年 | 50篇 |
2016年 | 65篇 |
2015年 | 59篇 |
2014年 | 81篇 |
2013年 | 109篇 |
2012年 | 143篇 |
2011年 | 162篇 |
2010年 | 102篇 |
2009年 | 83篇 |
2008年 | 124篇 |
2007年 | 119篇 |
2006年 | 74篇 |
2005年 | 96篇 |
2004年 | 68篇 |
2003年 | 68篇 |
2002年 | 73篇 |
2001年 | 14篇 |
2000年 | 12篇 |
1999年 | 12篇 |
1998年 | 21篇 |
1997年 | 10篇 |
1996年 | 10篇 |
1995年 | 6篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 7篇 |
1983年 | 3篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 8篇 |
1978年 | 5篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1969年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有1957条查询结果,搜索用时 265 毫秒
11.
12.
Three‐dimensional transesophageal echocardiography incremental value in a rare case of a bileaflet tricuspid valve 下载免费PDF全文
Hani M. Mahmoud M.B.B.Ch M.Sc. F.A.S.E. Hossam Walley M.D. Hatem Hosny M.Sc. Magdi Yacoub F.R.C.S. F.R.S. 《Echocardiography (Mount Kisco, N.Y.)》2016,33(9):1438-1440
Detailed assessment of the tricuspid valve using two‐dimensional echocardiography is always challenging, as only two of three leaflets can be seen at a time. Three‐dimensional echocardiography can provide the enface view of the tricuspid valve that allows simultaneous visualization of all of the three leaflets. In a 42‐year‐old male patient scheduled for pulmonary endarterectomy, 3DTEE showed that the tricuspid valve is bileaflet, with one septal and another lateral leaflet. There were two commissures, one of them is anteriorly positioned and the other one is posterior. Our findings were confirmed intra‐operatively by direct surgical visualization of the tricuspid valve. 相似文献
13.
Yahya A. Al-Zahrani Sameer E. Al-Harthi Lateef M. Khan Hani M. El-Bassossy Sherif M. Edris Mai A. Alim A. Sattar 《Saudi Pharmaceutical Journal》2015,23(5):487-498
The anti-anginal effects of allopurinol were assessed in experimental model rats of angina and their effects were evaluated with amlodipine. In the vasopressin-induced angina model, oral administration of allopurinol in dose of 10 mg/kg revealed remarkably analogous effects in comparison with amlodipine such as dose-dependent suppression of vasopressin-triggered time, duration and severity of ST depression. In addition, allopurinol produced dose dependent suppression of plasma Malondialdehyde (MDA) level, systolic blood pressure, cardiac contractility and cardiac oxygen consumption; while in contrast, amlodipine minimally suppressed the elevation of plasma MDA level. Endothelial NO synthase (eNOS) expression, serum nitrate were strikingly increased, however lipid profile was significantly reduced. Seemingly, allopurinol was found to be more potent than amlodipine – a calcium channel antagonist. To conclude, it was explicitly observed and verified that on the ischemic electrocardiography (ECG) changes in angina pectoris model in rats, allopurinol exerts a significant protective effects, reminiscent of enhancement of vascular oxidative stress, function of endothelial cells, improved coronary blood flow in addition to the potential enhancement in myocardial stress. Moreover, our findings were in conformity with several human studies. 相似文献
14.
15.
Bassel El Zorkany Nizar Al Ani Samar Al Emadi Jamal Al Saleh Imad Uthman Yasser El Dershaby Mohamed Mounir Hani Al Moallim 《Clinical rheumatology》2018,37(5):1143-1152
The increasing availability of biosimilar medicines in Middle Eastern regions may provide an opportunity to increase the number of rheumatology patients who have access to traditionally more expensive biologic medicines. However, as well as a lack of real-world data on the use of biosimilar medicines in practice, the availability of intended copies in the region may undermine physician confidence in prescribing legitimate biosimilar medicines. There is a need for regional recommendations for healthcare professionals to ensure that biosimilar drugs can be used safely. Therefore, a literature search was performed with the aim of providing important recommendations for the regulation and use of biosimilar medicines in the Middle East from key opinion leaders in rheumatology from the region. These recommendations focus on improving the availability of relevant real-world data, ensuring that physicians are aware of the difference between intended copies and true biosimilars and ensuring that physicians are responsible for making any prescribing and switching decisions. 相似文献
16.
17.
18.
19.
Rima Moghnieh Dania Abdallah Lyn Awad Tamima Jisr Anas Mugharbil Ali Youssef Hani Tamim Samer Khaldieh Oula Massri Najat Rashini Youssef Hamdan Ahmad Ibrahim 《Infection》2018,46(6):823-835
Purpose
In this study, we assessed the incidence, contributing factors and outcome of prolonged neutropenia above 7 days and of bacteraemia in patients with lymphoma and multiple myeloma who underwent autologous haematopoietic stem cell transplantation (AHSCT) without antibacterial prophylaxis.Methods
This is a retrospective chart review of 190 adult patients who underwent AHSCT between 2005 and 2015 at a Lebanese hospital.Results
Neutropenia of 7 days duration and longer was documented in 66% of the patient population. Through univariate analysis, patients with lymphoma were significantly more likely to have prolonged neutropenia (≥?7 days) compared to those with myeloma. Mucositis above grade 3, diarrhoea and fever were more likely to occur in patients with prolonged neutropenia. Bacteraemia was documented in 12.6% of the patients. Total mortality rate was 3.7%, and that attributed to bacteraemia was 12.5% in the bacteraemia subgroup. Among bacterial isolates recovered from clinical specimens (89 isolates), 70% were Gram-negative, of which 57% were fluoroquinolone susceptible. Ninety-five percent of the Gram-negative bacteria causing bacteraemia were susceptible to fluoroquinolones.Conclusion
Bacterial pathogens causing bacteraemia were still highly susceptible to fluoroquinolones, despite the high prevalence of fluoroquinolone-resistant strains in the general bacterial ecology. Accordingly, the pertinence of fluoroquinolone prophylaxis in the AHSCT setting warrants further investigation. Moreover, continuous surveillance of local antibiograms in this patient population has become a must in an era of preponderant antibiotic resistance.20.
Chayakrit Krittanawong Ameesh Isath Joshua Hahn Zhen Wang Sonya E. Fogg Dhrubajyoti Bandyopadhyay Hani Jneid Salim S. Virani W.H. Wilson Tang 《The American journal of medicine》2021,134(5):637-642.e2
IntroductionEdible mushrooms have a great nutritional value including high protein, essential amino acids, fiber, vitamins (B1, B2, B12, C, and D), minerals (calcium [Ca], potassium [K], magnesium [Mg], sodium [Na], phosphorus [P], copper [Cu], iron [Fe], manganese [Mn], and selenium [Se]), low fatty foods, and sodium. The objective of this systematic review was to determine the relationship between edible mushroom consumption and overall cardiovascular risk.MethodsWe systematically searched Ovid MEDLINE, Embase, Ovid Cochrane Database of Systematic Reviews, Scopus, and Web of Science from database inception from 1966 through August 2020 for observational studies that reported the association between edible mushroom consumption and cardiovascular risk. Two investigators independently reviewed data. Conflicts were resolved through consensus discussion.ResultsOf 1479 studies, we identified 7 prospective studies. Edible mushroom consumption may have favorable effects on lipid profiles by changing some metabolic markers such as low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol, and triglycerides. Moreover, edible mushroom consumption is probably associated with reduced mean blood pressure. The beneficial overall cardiovascular risk, stroke risk, and coronary artery disease of edible mushroom consumption are not consistent.ConclusionsEdible mushroom consumption has not been shown to conclusively affect cardiovascular risk factors to date. However, potential health benefits may exist, including a favorable alteration of lipid profiles and blood pressure reduction. 相似文献